Cost-effectiveness of treatment alternatives in Parkinson's disease. An evaluation using a Markov decision analytic model

被引：0
|
作者：
Dodel, R
Spottke, A
Oertel, WH
Poewe, W
Sampaio, C
Siebert, U
机构：
来源：
MOVEMENT DISORDERS | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of abciximab after coronary stenting: A decision-analytic model
    Rodriguez, O
    Cutlip, DE
    Kuntz, RE
    Cohen, DJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 51A - 51A
  • [32] Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model
    G. Feljandro P. Ramos
    Antoinette D. I. van Asselt
    Sandra Kuiper
    Johan L. Severens
    Tanja Maas
    Edward Dompeling
    J. André Knottnerus
    Onno C. P. van Schayck
    The European Journal of Health Economics, 2014, 15 : 869 - 883
  • [33] Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model
    Ramos, G. Feljandro P.
    van Asselt, Antoinette D. I.
    Kuiper, Sandra
    Severens, Johan L.
    Maas, Tanja
    Dompeling, Edward
    Knottnerus, J. Andre
    van Schayck, Onno C. P.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 (08): : 869 - 883
  • [34] Fitting nutrition into the medical model: the role of decision analytic cost-effectiveness techniques
    EM Ross
    IH Rosenberg
    B Dawson-Hughes
    NF Col
    JB Wong
    European Journal of Clinical Nutrition, 1999, 53 : s25 - s28
  • [35] COST-EFFECTIVENESS OF MATERNAL TOXOPLASMA SCREENING IN AUSTRIA: A DECISION-ANALYTIC MODEL
    Prusa, A. R.
    Walter, E.
    Pollak, A.
    Hayde, M.
    Kasper, D. C.
    VALUE IN HEALTH, 2013, 16 (07) : A333 - A333
  • [36] Fitting nutrition into the medical model: the role of decision analytic cost-effectiveness techniques
    Ross, EM
    Rosenberg, IH
    Dawson-Hughes, B
    Col, NF
    Wong, JB
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 1999, 53 (Suppl 2) : S25 - S28
  • [37] A methodological approach to assess cost data in the context of a decision analytic model to evaluate the cost-effectiveness of the treatment of the metabolic syndrome
    Aidelsburger, P
    Wasem, J
    VALUE IN HEALTH, 2005, 8 (06) : A68 - A68
  • [38] EVALUATING PARTITIONED SURVIVAL MODEL AND MARKOV DECISION ANALYTIC MODEL APPROACHES FOR USE IN COST-EFFECTIVENESS ANALYSIS: ESTIMATING AND VALIDATING SURVIVAL OUTCOMES
    Smare, C.
    Lakhdari, K.
    Doan, J.
    Johal, S.
    VALUE IN HEALTH, 2017, 20 (05) : A310 - A310
  • [39] Dynamic treatment selection and modification for personalised blood pressure therapy using a Markov decision process model: a cost-effectiveness analysis
    Choi, Sung Eun
    Brandeau, Margaret L.
    Basu, Sanjay
    BMJ OPEN, 2017, 7 (11):
  • [40] Bimatoprost, latanoprost, and travoprost for the treatment of glaucoma: A cost-effectiveness analysis in Scandinavia using a decision-analytic health economic model
    Stewart, W. C.
    Stewart, J. A.
    Passmore, C. L.
    Mychaskiw, M. A.
    VALUE IN HEALTH, 2006, 9 (06) : A369 - A370
12345